In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model

Infection and Immunity

Volumn 83, Issue 1, 2015, Pages 77-89

  Bitsaktsis, Constantine ^a   Babadjanova, Zulfia ^a   Gosselin, Edmund J ^b  

^a SETON HALL UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; FC RECEPTOR; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; BACTERIUM ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FRANCISELLA TULARENSIS; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; INTERNALIZATION; LYMPHOID TISSUE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; NOSE MUCOSA; TULAREMIA; ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FRANCISELLA TULARENSIS; MICE, INBRED C57BL; RECEPTORS, FC; TULAREMIA;

EID: 84919497087     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02289-14     Document Type: Article

References (40)

1. Czerkinsky C, Holmgren J. 2012. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues. Curr Top Microbiol Immunol 354:1-18. http://dx.doi.org/10.1007/82_2010_112.
2. Rawool DB, Bitsaktsis C, Li Y, Gosselin DR, Lin Y, Kurkure NV, Metzger DW, Gosselin EJ. 2008. Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis. J Immunol 180:5548-5557. http://dx.doi.org/10.4049/jimmunol.180.8.5548.
3. Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ. 2012. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcgamma receptor type I protects against pneumococcal infection through complement-and lactoferrin-mediated bactericidal activity. Infect Immun 80:1166-1180. http://dx.doi.org/10.1128/IAI.05511-11.
4. Iglesias BV, Bitsaktsis C, Pham G, Drake J R, Hazlett KR, Porter K, Gosselin EJ. 2013. Multiple mechanisms mediate enhanced immunity generated by mAb-inactivated F. tularensis immunogen. Immunol Cell Biol 91:139-148. http://dx.doi.org/10.1038/icb.2012.66.
5. Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch J V, Young JW. 2005. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 115:2914-2923. http://dx.doi.org/10.1172/JCI24772.
6. Kronin V, Wu L, Gong S, Nussenzweig MC, Shortman K. 2000. DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses. Int Immunol 12:731-735. http://dx.doi.org/10.1093/intimm/12.5.731.
7. Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, Brimnes MK, Moltedo B, Moran TM, Steinman RM. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 199:815-824. http://dx.doi.org/10.1084/jem.20032220.
8. Higgins DM, Sanchez-Campillo J, Rosas-Taraco AG, Higgins J R, Lee EJ, Orme IM, Gonzalez-Juarrero M. 2008. Relative levels of M-CSF and GM-CSF influence the specific generation of macrophage populations during infection with Mycobacterium tuberculosis. J Immunol 180:4892-4900. http://dx.doi.org/10.4049/jimmunol.180.7.4892.
9. Meyts I, Hellings PW, Hens G, Vanaudenaerde BM, Verbinnen B, Heremans H, Matthys P, Bullens DM, Overbergh L, Mathieu C, De Boeck K, Ceuppens JL. 2006. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J Immunol 177:6460-6470. http://dx.doi.org/10.4049/jimmunol.177.9.6460.
10. Witmer-Pack MD, Swiggard WJ, Mirza A, Inaba K, Steinman RM. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues. Cell Immunol 163:157-162.
11. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712. http://dx.doi.org/10.1038/44385.
12. Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N, Washabaugh MW. 2003. Memory T cells and vaccines. Vaccine 21: 419-430. http://dx.doi.org/10.1016/S0264-410X(02)00407-3.
13. Kaech SM, Wherry EJ, Ahmed R. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2:251-262. http://dx.doi.org/10.1038/nri778.
14. Conlan J W, Sjostedt A, North RJ. 1994. CD4+ and CD8+ T-celldependent and-independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect Immun 62:5603-5607.
15. Yee D, Rhinehart-Jones TR, Elkins KL. 1996. Loss of either CD4+ or CD8+T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol 157: 5042-5048.
16. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549. http://dx.doi.org/10.1126/science.8097338.
17. Liu J, Cao S, Herman LM, Ma X. 2003. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gammaprimed IL-12 production by IFN regulatory factor 1. J Exp Med 198:1265-1276. http://dx.doi.org/10.1084/jem.20030026.
18. Chirdo FG, Millington OR, Beacock-Sharp H, Mowat AM. 2005. Immunomodulatory dendritic cells in intestinal lamina propria. Eur J Immunol 35:1831-1840. http://dx.doi.org/10.1002/eji.200425882.
19. Anjuère F, Luci C, Lebens M, Rousseau D, Hervouet C, Milon G, Holmgren J, Ardavin C, Czerkinsky C. 2004. In vivo adjuvant-induced mobilization and maturation of gut dendritic cells after oral administration of cholera toxin. J Immunol 173:5103-5111. http://dx.doi.org/10.4049/jimmunol.173.8.5103.
20. Jaensson E, Uronen-Hansson H, Pabst O, Eksteen B, Tian J, Coombes JL, Berg PL, Davidsson T, Powrie F, Johansson-Lindbom B, Agace WW. 2008. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 205: 2139-2149. http://dx.doi.org/10.1084/jem.20080414.
21. Wikstrom ME, Batanero E, Smith M, Thomas J A, von Garnier C, Holt PG, Stumbles PA. 2006. Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen. J Immunol 177:913-924. http://dx.doi.org/10.4049/jimmunol.177.2.913.
22. Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med 193:51-60. http://dx.doi.org/10.1084/jem.193.1.51.
23. Cyster JG. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286:2098-2102. http://dx.doi.org/10.1126/science.286.5447.2098.
24. Sallusto F, Lanzavecchia A. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 189:611-614. http://dx.doi.org/10.1084/jem.189.4.611.
25. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, Forster R, Burgstahler R, Lipp M, Lanzavecchia A. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29:1617-1625. http://dx.doi.org/10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3.
26. Dieu MC, Vanbervliet B, Vicari A, Bridon J M, Oldham E, Ait-Yahia S, Briere F, Zlotnik A, Lebecque S, Caux C. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188:373-386. http://dx.doi.org/10.1084/jem.188.2.373.
27. Chiu BC, Freeman CM, Stolberg VR, Hu J S, Zeibecoglou K, Lu B, Gerard C, Charo IF, Lira SA, Chensue SW. 2004. Impaired lung dendritic cell activation in CCR2 knockout mice. Am J Pathol 165:1199-1209. http://dx.doi.org/10.1016/S0002-9440(10)63380-9.
28. Osterholzer JJ, Curtis JL, Polak T, Ames T, Chen GH, McDonald R, Huffnagle GB, Toews GB. 2008. CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans. J Immunol 181:610-620. http://dx.doi.org/10.4049/jimmunol.181.1.610.
29. Bar-Haim E, Gat O, Markel G, Cohen H, Shafferman A, Velan B. 2008. Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection. PLoS Pathog 4:e1000211. http://dx.doi.org/10.1371/journal.ppat.1000211.
30. Chiavolini D, Rangel-Moreno J, Berg G, Christian K, Oliveira-Nascimento L, Weir S, Alroy J, Randall TD, Wetzler LM. 2010. Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia. PLoS One 5:e11156. http://dx.doi.org/10.1371/journal.pone.0011156.
31. Ancuta P, Pedron T, Girard R, Sandstrom G, Chaby R. 1996. Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect Immun 64:2041-2046.
32. Dueñas AI, Aceves M, Orduna A, Diaz R, Sanchez Crespo M, Garcia-Rodriguez C. 2006. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS. Int Immunol 18:785-795.
33. Campbell JJ, Butcher EC. 2000. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12: 336-341. http://dx.doi.org/10.1016/S0952-7915(00)00096-0.
34. Gunn MD, Tangemann K, Tam C, Cyster J G, Rosen SD, Williams LT. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A 95:258-263. http://dx.doi.org/10.1073/pnas.95.1.258.
35. Roberts AD, Ely KH, Woodland DL. 2005. Differential contributions of central and effector memory T cells to recall responses. J Exp Med 202: 123-133. http://dx.doi.org/10.1084/jem.20050137.
36. Blander JM, Sant'Angelo DB, Metz D, Kim SW, Flavell RA, Bottomly K, Janeway CA, Jr. 2003. A pool of central memory-like CD4 T cells contains effector memory precursors. J Immunol 170:2940-2948. http://dx.doi.org/10.4049/jimmunol.170.6.2940.
37. Gurunathan S, Prussin C, Sacks DL, Seder RA. 1998. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat Med 4:1409-1415. http://dx.doi.org/10.1038/4000.
38. Elkins KL, Cooper A, Colombini SM, Cowley SC, Kieffer TL. 2002. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect Immun 70:1936-1948. http://dx.doi.org/10.1128/IAI.70.4.1936-1948.2002.
39. Pammit MA, Budhavarapu VN, Raulie EK, Klose KE, Teale J M, Arulanandam BP. 2004. Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection. Antimicrob Agents Chemother 48:4513-4519. http://dx.doi.org/10.1128/AAC.48.12.4513-4519.2004.
40. Duckett NS, Olmos S, Durrant DM, Metzger DW. 2005. Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain. Infect Immun 73:2306-2311. http://dx.doi.org/10.1128/IAI.73.4.2306-2311.2005.